Integra LifeSciences IART Long-term borrowings under securitization facility
Long-term borrowings under securitization facility at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept iart:SecuredLongTermDebtSecuritizationProgramNoncurrent.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's long-term borrowings under securitization facility.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's long-term borrowings under securitization facility?
- Integra LifeSciences (IART) reported long-term borrowings under securitization facility of $76.4M in Q1 2026.
- How has Integra LifeSciences's long-term borrowings under securitization facility changed year-over-year?
- Integra LifeSciences's long-term borrowings under securitization facility decreased by 25.2% year-over-year, from $102.1M to $76.4M.
- What does long-term borrowings under securitization facility mean?
- This represents the long-term portion of debt obligations financed through a securitization program that is due beyond the next twelve months. It highlights the company's long-term capital structure strategy and the extent to which it leverages specific asset classes to secure financing. This metric is essential for evaluating the company's long-term leverage profile and the stability of its debt funding sources.